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Abstract 
 
BACKGROUND: Caffeine has been shown to increase energy expenditure, being a good 
candidate ingredient for thermogenic beverages. CO2 is commonly used by the 
pharmaceutical industry to increase the absorption of drugs. Whether CO2 addition to a 
caffeinated beverage could increase caffeine absorption and its thermogenic effects is 
unknown. OBJECTIVE: Determine if effervescence could increase the effects of caffeine on 
energy metabolism. DESIGN: 12 healthy Caucasian followed a randomized, crossover, single-
blind, controlled pilot study. Subjects ingested at two different occasions either a still or a 
carbonated beverage containing same dose of caffeine (100 mg) and green tea catechins. 
MEASUREMENTS: Pre- (15 min) and post-treatment ingestion (120 min) energy expenditure 
(EE) was measured by indirect calorimetry using a canopy system. Substrate oxidation and 
heart rate were measured during the same time-periods. Caffeine kinetics was evaluated in 
saliva over 120 min. RESULTS: Caffeine AUC and Cmax were increased over 120 min (10.1 
µg.min/mL, p = 0.040 and 0.19 µg/mL, p = 0.031, respectively) with the carbonated 
compared to the still treatment. No difference between treatments was observed for 
change in EE. Both treatments increased EE by 6 kcal compared to baseline (p < 0.040). Over 
120 min, still treatment enhanced fat and decreased carbohydrate oxidation by 17.2 kcal (p 
= 0.004) and 13.3 kcal (p = 0.012), respectively, compared to baseline. CONCLUSION: 
Caffeine absorption was increased with the carbonated, compared to the still treatment. 
However, this was not accompanied by an increase in EE compared to still treatment. Still 
treatment shifted substrate oxidation towards fat, reducing the contribution of 
carbohydrate as a body fuel. The significant increase in EE induced by both treatments 
confirms the thermogenic properties of the beverage formulation, independently from its 
CO2 content. 
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Complementary activities at the Nestlé Research Center 
 
 
Indirect calorimetry was not new at NRC, since the first instruments were implemented 
there in 1988. But the recent acquisition of 3 new setups (MAX-II device provided by AEI 
technologies, Naperville, IL, USA) required their installation, the check of their good 
functioning, as well as the conformation to NRC quality requirements. 
My internship began just when the devices arrived at NRC. Therefore, I was involved into all 
these processes. Indeed, after a first literature review to understand the technique, I was 
trained to use the devices by two experts in the field, the scientist Geneviève Major, PhD 
and the senior scientist Kevin Acheson, PhD. In order to comply with quality requirements, 
and after a training period, I contributed to the development, writing and implementation of 
a Standard Operating Procedure (SOP) on the indirect calorimetry devices. This document 
was published internally, and is now a reference on the use of the indirect calorimetry 
setups at NRC. 
 
Once the equipment was in agreement with quality standards, I was the main operator in 
charge of measuring energy expenditure of 72 volunteers in a double-blind, randomized, 
controlled, parallel-design study of two groups. I performed that work part time from 
October 2009 to May 2010. The energy expenditure measurements lasted 30-min, and each 
participant was tested twice, in fasting state. Prior to the beginning of this study, I measured 
the caloric content of the meals that were given to the subjects to test their ad libitum 
energy intake. This was done by burning pellets of dehydrated mashed food into an oxygen 
combustion bomb (calorimeter provided by Parr instrument company, IL, USA), and 
measuring the temperature increase of the water surrounding the bomb (water volume was 
precisely known).  
 
I was also involved in discussions related to the development the present pilot study. 
Therefore, I reviewed the literature concerning carbonation, caffeine and carbonation, 
caffeine and energy expenditure and wrote the study protocol under Dr Major’s supervision 
and in line with the good clinical practices (GCPs). After this step, and in constant 
collaboration with the Metabolic Unit at the NRC, the protocol was sent to the Ethics Comity 
of the CHUV for approval. 
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Once approved, subjects were recruited by the Metabolic Unit at the NRC. I was the main 
operator in charge of measuring energy expenditure, together with another research 
assistant. I was therefore blind to the study treatments the participants received. The setting 
of the rooms where energy expenditure is recorded had to be adapted to the new study, 
and I found solutions for to adapt the room setup, allowing the participants to be able to 
ingest treatments without disturbing energy expenditure measurements. 
After the end of the recordings, and for each subject, I developed and implemented that 
concept of a “Dossier santé” which is a small document to communicate to participant their 
own energy expenditure and heart rate results. Individual results were explained and 
compared to “normal” values, and sent to each subject. 
Conjointly with a mass spectrometry expert, I worked to develop a UPLC (ultra pressure 
liquid chromatography) method to analyze caffeine content in saliva, and did the analysis of 
the saliva samples. 
It has to be mentioned that achieving the present study in less than 5 months was only 
possible due to the fact that I was already familiar with the indirect calorimetry setup prior 
the beginning of the clinical phase, and that every person involved into the study gave its 
best to work efficiently. 
I also contributed to writing an invited review for the Journal of Applied Physiology, 
Nutrition and Metabolism (National Research Council Canada Press), on the topic of 
micronutrients and obesity. The review will soon be submitted for publication. 
 
 
Over all the internship, I worked as technician, research assistant and study coordinator, and 
took active part to the life of the research group. I attended to weekly group meeting 
presentations and monthly seminars of the Department of Nutrition and Health. I also did a 
seminar to present the results of my study to the Energy and Metabolic Health Group. The 
variety of tasks I performed during my 11 months of internship gave me the opportunity to 
become more familiar with a clinical research environment and the main activities related to 
clinical studies.  
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1 Introduction  
 
The incidence of obesity is dramatically increasing worldwide reflecting a daily positive 
energy imbalance in a large part of the population 70. Matching energy intake with energy 
expenditure favors energy balance which is synonymous with body weight maintenance. 
Although a macronutrient balanced diet and regular physical activity are the best ways to 
ensure this match, ingredients that have the potential to increase mitochondrial activity37,56 
and subsequently diet-induced energy expenditure can complement a healthy lifestyle and 
help energy balance maintenance. Indeed, estimation from population studies revealed that 
a positive energy balance as low as 50-100 kcal/d could explain the annual 1-2 pound body 
weight gain (~ 0.5-1 kg) that occurred during the last decade in the American population 34,35. 
This corresponds to the modest quantitative range of contribution to total energy 
expenditure that can be expected from thermogenic ingredients considered safe for food 
application 68. Therefore, continuous improvement of existing products formulated to 
increase energy expenditure in order to try to enhance their effect is on avenue to help 
healthy-weight conscious people meet their objective. 
 
1.1 Energy expenditure: where does it come from and how to measure it? 
Energy expenditure can be divided into three main components: resting EE (REE), thermic 
effect of food and physical activity EE 32. REE is energy spent to sustain basic life processes 
during awaken state, accounting for ~ 60-75 % of total daily energy expenditure 59. Thermic 
effect of food is the energy expended for food processing such as mastication, digestion and 
absorption. Physical activity is the most variable component of EE, since it depends on each 
individual’s engagement in exercise. It accounts for ~ 20-40% of EE 59.  
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In animal cells, mitochondrion is the organelle responsible for the transformation of most of 
the metabolic energy 32. In this compartment, production of ATP occurs through cellular 
respiration, the main process that consumes O2 and releases CO2, in healthy subjects 
48. CO2 
is a by-product of the citric acid cycle that oxidizes acetyl CoA to give rise to high energy 
NADH. NADH transmits its energy to the electron transport chain, where O2 is consumed, to 
build an acidic gradient in the inter membrane space of the mitochondria. This gradient is 
the driving force to create ATP from ADP. The overall balance involves that production of 
cellular energy requires consumption of O2 and production of CO2 eliminated through 
respiration 4,48. Mitochondrion is the only site of utilization of oxygen, since O2 cannot be 
stored in the body. Moreover, cellular respiration is the only mechanism of CO2 release in 
normal conditions (no acidosis or alkalosis). Thus, in healthy subjects, assumption is made 
that all O2 consumed and all CO2 released by respiration is due to cellular respiration in 
mitochondria, and reflects entire body EE 48. A rough overview of cellular energy generation 
by the mitochondrion is schematized in Fig. 1. 
 
 
 
 
 
 
 
 
 
 
Figure 1 Cellular respiration and energy production: production of ATP requires O2 
consumption and CO2 release from the mitochondrion. Modified from “Molecular Biology of 
the Cell” 4 
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Evaluation of energy expenditure using indirect calorimetry is realized by measuring 
respiratory gas exchange (oxygen consumption and carbon dioxide production), which 
allows to estimate the amount of calories “burned”. This technique can be used from mouse 
to man. Its reliability, relatively low initial and maintenance costs plus the fact that it can 
describe precisely the type of substrate being oxidized make indirect calorimetry a very good 
method to measure energy expenditure.   
Expiratory gases are collected and their O2 and CO2 content are measured. They are 
compared to the O2 and CO2 content of the ambient air that is breathed in by the participant. 
The difference between ambient and expired O2 and CO2 concentrations is assumed to be 
entirely due to the cellular respiration48, and to reflect energy expenditure. In practice, 
indirect calorimetry measurements can be performed when volunteers are in a metabolic 
chamber, or when they wear a canopy or a mask. The ambient air is pulled into the 
compartment where subjects breathe, and their respiratory gases are pulled towards the gas 
analyzer, through a unidirectional valve that prevents gas reflux. 
The gold standard equation to determine energy expenditure is the simplified Weir 
formula67:      
EE (kcal/min) = )106.1()941.3( 22 VCOVO       Equation 1 
 
Moreover, the type of substrate that is being oxidized (fat or carbohydrate) can be derived 
from this method, either in observing the ratio of carbon dioxide production to oxygen 
consumption, or in evaluating the weight of substrate oxidized.  
 
Oxidation of food substrate into the mitochondria consumes O2 and releases CO2. Therefore, 
measurements of expiratory O2 and CO2 allow the estimation of substrate oxidation
48. 
Indeed, oxidation of glucose (C6H12O6 + 6 O2 → 6 CO2 + 6 H2O) requires 6O2 and releases  
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6CO2, whereas oxidation of linoleic acid consumes 51O2 and produces 36CO2. The method 
relies on the ratio of carbon dioxide production to oxygen consumption, which gives the 
respiratory quotient (RQ). It can be assumed to reflect total whole body oxidation of the 
three principal macronutrients: carbohydrate, fat, and protein. The changes in the RQ reflect 
the type of substrate that the body is currently oxidizing, see Fig. 2. In normal physiological 
conditions39, this parameter can vary between 1 and 0.7. A RQ of 1 indicates that the 
metabolism rely totally on carbohydrate oxidation, whereas a RQ of 0.7 indicates that fat 
fuels the energy metabolism46. In between values (i.e. interval ] 0.7 ; 1.0 [ ), indicate that the 
metabolism relies partly on carbohydrate, partly on fat, and partly on protein.  
The gold standard to evaluate substrate oxidation by observing the RQ is the use of 
equations of Livesey and Elia46:  
RQ (no unit) = 
2
2
VO
VCO
      Equation 2 
As protein oxidation represents a minimal part of whole oxidation in a normal situation (no 
prolonged starvation, no diabetes, no acidosis)46, it can be assumed to remain constant. 
Protein oxidation can be measured through urine nitrogen. Another method is to estimate 
protein oxidation based on the weight of subjects, using with the following equations 1: 
Protein oxidation (mg/min) = 
1440
1000*).*8.0( weightbody
     Equation 3 
Once protein oxidation has been determined, it is possible to derive the non-protein oxygen 
consumption (NPVO2) and the non-protein carbon dioxide production (NPVCO2)
46. These 
variables reflect O2 consumption and CO2 production that does not take into account the 
portion of gas due to protein oxidation. 
NPVO2 (ml/min) = 01031.1.2  oxidationproteinVO     Equation 4 
NPVCO2 (ml/min) = 84361.0.2  oxidationproteinVCO     Equation 5 
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To calculate the respiratory quotient without taking into account protein oxidation, non-
protein respiratory quotient (NPRQ) can be derived from NPVO2 and NPVCO2 (Eq. 4 and Eq. 
5). 
NPRQ (no unit) = 
2
2
NPVO
NPVCO
    Equation 6 
 
 
 
 
 
If it is assumed that protein contributes minimally to the three substrate oxidized46, NPRQ‘s 
interpretation is the same than RQ. 
 
From NPVO2 and NPVCO2, it is possible to calculated fat and carbohydrate oxidations
46: 
 Fat (mg/min) = 
)707.01(01494.2
22

 NPVCONPVO
   Equation 7 
Carbohydrate (mg/min) = 
)707.01(82821.0
707.0 22

 NPVONPVCO
   Equation 8 
 
In these equations,  energy expenditure is expressed in kcal/min 
          VO2, VCO2, NPVO2 and NPVCO2 are expressed in ml/min 
          Protein, fat and carbohydrate oxidation are expressed in mg/min 
          RQ and NPRQ have no unit 
          Body weight is expressed in kg 
Figure 2 Interpretation of NPRQ evolution 
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Energy expenditure can be modulated by changing physical activity practice or using 
functional food to modulate the metabolic rate. Among such thermogenic ingredients, 
caffeine, and to a lower extend tea catechins, have been shown to enhance EE. 
 
1.2 Caffeine and catechins impact on thermogenesis and substrate oxidation 
 
1.2.1 Caffeine 
 
Caffeine belongs to the alkaloid group, and is part of the methylxanthine family, Fig. 3. 
 
 
 
 
After ingestion, caffeine is absorbed in the intestine (80%) and in the stomach (20%)19. 
Although this molecule is hydrophilic, it has sufficient hydrophobic characteristics to cross all 
biological membranes, and is therefore highly bioavailable6. In human, 99% of the ingested 
caffeine is absorbed within 45 min13. Its half-life, in human, is around 4.9h 57,58, but is 
subjected to important inter-subjects variability12. In human, caffeine is primarily 
metabolized in the liver with the intervention of the cytochrome P450 oxidase enzyme 1A218. 
Demethylation of caffeine gives rise to paraxanthine (84%), theobromine (12%) and 
theophilline (4%) 44.  
 
Among the numerous effects of caffeine on the metabolism, its effect on energy metabolism 
has been widely studied. Acute increase in energy expenditure varying between 3 and 16% 
increase with doses between 100 and 400 mg caffeine intake has been reported by different 
authors 2,3,5,8,16,26,36,41. The thermogenic effect of caffeine is thought to be mainly due to 
Figure 3 Caffeine’s developped formula ; 1, 3, 7 tri-methylxanthine, C8H10N4O2 
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three mechanisms: adenosine receptor blockage, phosphodiesterase inhibition and 
ryanodine receptor stimulation. These mechanisms impact either on SNS or directly on 
muscle stimulation, increasing thermogenesis and lipolysis. 
 
Adenosine receptors blockage (Mecanism 1, Fig. 4) 
Adenosine is a neurotransmitter distributed through all the body, which acts on specific cell-
surface receptors47. Its binding to its receptor leads to inhibition of the release of many 
neurotransmitters, such as norepinephrine (NE), dopamine, acetylcholine, glutamate and 
GABA29. As shown in Fig. 4 mechanism 1, caffeine can bind to the adenosine receptors. This 
leads to inhibition of the activity of this receptor, thus increasing the release of the above-
cited neurotransmitters, among which NE, enhancing its effects on SNS24. More NE in the 
circulation will further activate β-adrenergic receptors on effector cells, and as a 
consequence, drive the conversion of ATP into cAMP by adenylate cyclase48. Intracellular 
cAMP signaling produces heat in skeletal muscle and leads to increased lipolysis10. 
 
Phosphodiesterase  (Mechanism 2, Fig. 4). 
cAMP, a G-protein second messenger, is degraded to AMP by the widely distributed enzyme 
phosphodiesterase48. Caffeine can inhibit phosphodiesterase (Fig. 4 mechanism 2), i.e. 
increase cAMP lifespan by preventing its degradation27, leading to increased cAMP levels. 
Phosphodiesterase inhibition by caffeine has been triggered in vitro with above physiological 
ranges of caffeine, thus indicating a rather minimal effect of this phenomenon at normal 
caffeine consumption in human53. 
 
It is to note that both binding of adenosine receptor and inhibition of phosphodiesterase are 
complementary in leading to increased cAMP levels. These enhance thermogenesis and 
activate hormone sensitive lipase, which promotes free fatty acids (FFA) in circulation. FFA 
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can further fuel ATP production by mitochondria, as shown in Fig. 1. Thus, caffeine triggers 
fat oxidation more than carbohydrate consumption 2,3,38 and increases thermogenesis.  
 
 
Release of intracellular calcium 
Finally, caffeine can act physiologically and independently of SNS, mainly by stimulating 
intracellular calcium release from sarcoplasmic reticulum in skeletal muscle53. The ryanodine 
receptor, a sarcoplasmic reticulum channel releasing calcium ions into skeletal muscles, can 
be activated by caffeine binding. Stimulation of the ryanodine receptor enhances the muscle 
contraction, promotes the production of heat, increases ATP turnover and mitochondrial 
pyruvate oxidation21. By influencing calcium mobilization in skeletal muscle, caffeine may 
impact global thermogenesis2. 
Figure 4 Effects of caffeine and green tea catechins on energy metabolism and substrate 
oxidation: increase free norepinephrine (activator of SNS), cAMP (mediator of cell 
thermogenesis) and lipolysis 
Abbreviations: AR: Adenosine Receptor; NE: Norepinephrine; βAR: Beta-Adreno Receptor; HSL : Hormone Sensitive 
Lipase; COMT: Catechol O-MethylTransferase 
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The role of resting muscle metabolism in inducing thermogenesis has been shown to be an 
important determinant of inter-individual variability in energy expenditure71. This could 
indicate that caffeine induced intramyocellar release of calcium is a mechanism impacting 
importantly on energy expenditure7. 
 
1.2.2 Catechins (Mechanism 3, Fig. 4) 
 
Catechin is another ingredient being extensively studied for its thermogenic properties. 
Catechins are part of the flavonoid family, and are found mainly in green tea. 
 
 
 
 
Catechins can interact in the NE pathway described above (Mechanism 3, Fig. 4). Indeed, 
catechol O-methyltransferase (COMT) is an enzyme, widely distributed in the body, which 
degrades several catecholic compounds, among which NE14. Green tea catechins, and mainly 
EGCG, can inhibit this enzyme69, leading to prolonged half-life of NE, thus extending its 
activation of β-adrenoreceptors and further cAMP synthesis, as shown in Fig. 4. This leads to 
enhanced energy expenditure and lipolysis.  
Moreover, a synergetic effect between green tea and caffeine is possible. Indeed, both 
caffeine and catechins act together to enhance the NE pathway (Fig. 4).  Caffeine inhibition 
of cAMP degradation will further increase the cAMP levels, leading to global SNS 
activation66,69. 
Beside these theoretical mechanisms, the clinical effects of catechins remain unclear. Indeed, 
125 mg of catechins triggered no increase in 4h-EE compared to baseline, in the study of 
Belza et al 10. This might be due to the dose that was too low to induce an effect on EE. 
Figure 5 Epigallactocatechin gallate’s developped formula ; one of the most potent catechin 
found in green tea 42 
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Alternatively, catechins might have to be ingested with caffeine to induce an effect on EE. 
Indeed, Dulloo et al suggested a synergistic effect, after having observed a significant 
increase in 24h-EE (2.8%) and fat oxidation in 10 human subjects, due to conjoint 
administration of caffeine and catechins (150 mg and 375 mg respectively) compared to 
ingestion of 150 mg of caffeine alone25. On the other hand, Gregersen et al showed that 600 
mg catechins plus 150 mg caffeine did not significantly increase 12.5h-EE more than caffeine 
alone (150 mg)31. Rumpler et al failed to demonstrate that 270 mg caffeine plus 244 mg 
EGCG had a greater effect on 24h-EE than 270 mg caffeine alone64. Finally, Thielecke et al 
observed that the effect on fat oxidation of 300 mg EGCG and 200 mg caffeine was mainly 
triggered by caffeine, since they did not observe a difference between this mixture and 200 
mg caffeine alone66. Moreover, Bérubé-Parent et al observed an 8 % increase in 24h-EE with 
EGCG-caffeine mixtures (per day: caffeine fixed dose of 600 mg plus either 270, 600, 900 or 
1200 mg EGCG) compared to placebo; but these doses did not impact fat oxidation and RQ11. 
Thus, even if catechins may have an effect on thermogenesis25, literature points towards a 
smaller impact compared to caffeine’s effect on energy expenditure and substrate 
oxidation10,11,23,31,64,66. 
 
1.3 Carbonation effects 
 
Carbonation and effervescence refer to the dissolution of CO2 into water or aqueous 
solution and to the release of CO2 from these solutions, respectively. There are few 
evidences suggesting that effervescence increases absorption and bioavailability of drugs. 
CIMA Laboratories patented in the US the use of effervescence as a penetration enhancer 
for drugs to improve their solubility and absorption in the gastro-intestinal tract54. This could 
be due to the effect of CO2 bubbling directly onto the intestinal epithelium which alters the 
paracellular pathway such as a reduction in transepithelial electrical resistance, as shown in 
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vitro on a rabbit ileum epithelium28. One randomized, double blind, placebo-controlled study 
compared an acetaminophen-standard to an acetaminophen-effervescent tablet and found 
that median times to onset of analgesia and meaningful pain relief was significantly shorter 
with the effervescent table51, also suggesting faster absorption with the effervescent 
medium. In accordance with this, Joshi et al showed a significantly shorter time to maximum 
plasma concentration of coenzyme Q10 administered with effervescent and fast-melting 
formulations compared with a soft-gel or powder-filled formulations, although no difference 
between the four formulations was observed for maximum plasma concentration and area 
under the curve40. Similarly, the rate of absorption, but not the maximum plasma 
concentration, was found to be significantly greater for a paracetamol effervescent powder 
compared to a paracetamol-coated tablet in healthy volunteers22. These results raise the 
question whether carbonation could have similar enhanced-absorption effects on 
ingredients that are dissolved in beverages for food application.  
 
Schroder et al compared in a randomized crossover study the intestinal calcium absorption 
between a dairy soft-drink, fat-free milk and a calcium-fortified orange juice and found a 
significantly higher calcium absorption in the first beverage65. In another trial implicating 21 
volunteers, mean absorption rate of alcohol was found to be significantly faster after 
consumption of vodka mixed with carbonated water compared to still water, although one 
third of participants in this study showed no difference or a decrease in absorption rate60. 
Few studies have also compared the absorption rate and kinetics of caffeine in carbonated 
and non-carbonated solutions. Liguori et al showed no difference in peak caffeine 
absorption and time to peak absorption between 400 mg caffeine administered via 12 oz 
unsweetened coffee, 24 oz sugar-free cola, or capsules in usual caffeine drinkers45. Bonati et 
al compared caffeine kinetics after consumption of 0.22 mg/kg of caffeine as soft-drink (190 
ml), 1.54 mg/kg as mocha coffee (50ml), 1.00 mg/kg as aqueous solution (70 ml at 0.1%),  
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5.00 mg/kg as aqueous solution (70 ml at 0.5 %), and 10.00 mg/kg as aqueous solution (70 
ml at 1.0 %) 13. They found similar kinetics between treatments, although in agreement with 
another study49, absorption rate constant was lower after the soft-drink compared to the 
mocha coffee and aqueous solution13. Bonati et al suggested that this difference could be 
due to the lower pH value, the larger volume and the lower concentration of the soft-drink 
compared to the other solutions. However, in this study, no p value was reported and it is 
therefore unknown if differences were significant. Moreover, kinetics data were obtained 
from four volunteers13.  
 
1.4 Study treatments 
 
In the scope of energy balance management, it is interesting to evaluate if carbonation can 
enhance caffeine-induced increase in energy expenditure. 
Building on the properties of caffeine and green tea to increase energy expenditure, Nestlé 
has developed the thermogenic ready-to-drink tea beverage. This tea beverage contains 
synthetic caffeine (65 mg), green tea extract (899 mg of which 230 mg are catechins, and 35 
mg are caffeine) and calcium (195 mg). The beverage exists in two versions containing the 
same active ingredients: one carbonated and one still. Therefore, this beverage represents a 
perfect candidate to answer the question whether CO2 can enhance the effect of caffeine 
and green tea catechins on energy metabolism. 
The acute effects of a mixture of active ingredients in similar proportion to what is found in 
still beverage has been tested, focusing mainly on energy expenditure, substrate oxidation 
and heart rate63.  In this study, three daily doses of this green tea and caffeine beverage was 
shown to significantly increase 24h-EE by 106 kcal in healthy, normal-weight men and 
women63. If Rudelle et al did not observe changes in fat oxidation following ingestion of 300  
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mg of caffeine and 540 mg catechins, the work of Dulloo et al 25 attested of an increase in fat 
oxidation and of a decrease in carbohydrate utilization after ingestion of 150 mg caffeine 
and 270 mg EGCG. Heart rate did not change in both studies 25,63. 
 
 
 
The following section summarizes the pilot clinical study conducted at the Nestlé Research 
Center, to compare the acute effect of carbonated compared to still study treatment on 
energy expenditure, substrate oxidation, heart rate and caffeine absorption. 
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2 Hypothesis 
 
Since carbon dioxide has been shown to enhance absorption28,54,65, the hypothesis of this 
study was that the increase in energy expenditure would be greater following ingestion of 
the carbonated, compared to the still study treatment, due to enhanced absorption of 
caffeine and green tea catechins, potentiating their thermogenic effects. This was addressed 
comparing, between treatments, the change in post-ingestion energy expenditure compared 
to baseline, over a 135 min measurement period (15 min baseline and 120 min post-
ingestion). As caffeine is known to impact substrate oxidation, this parameter was also 
evaluated in this study.  
Similarly, as caffeine is known to influence heart rate, at least at doses as high as 400 mg8, 
this variable was also measured. To match the evolution of these parameters with caffeine 
concentration and to evaluate the impact of carbonation on caffeine absorption, a kinetic of 
caffeine was derived from its concentration in saliva. It was hypothesized that caffeine 
would be absorbed faster and in larger proportion in the presence of carbon dioxide 
compared to the still beverage. 
 
 
Hypothesis: CO2 addition into treatment formulation may increase caffeine absorption. 
This may potentiate caffeine’s effects on energy expenditure, substrate oxidation and 
heart rate.  
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3 Materials and Methods 
 
For further information, a section “Subjects, Materials and Methods” is attached in Annex A.  
3.1 Study design  
This study is a single centered, randomized, single-blind, and controlled cross-over clinical 
trial of two groups.  
3.2 Product description 
 
 
3.3 Data collection 
 
Parameter  Stabilisation Pre-ingestion Ingestion Post-ingestion 
Time (min)                        -20                            -5                           0          15         30         60         90       //      120  
Salivette                                                         S0                                      S1         S2        S3         S4               S5  
EE  
Sub. Ox. 
Heart rate  
No 
measurement 
15 min 
measurement 
No 
measurement 
120 min measurement 
Table 2 Phases of measurement, timing and saliva sampling 
 
Visits one and two were identical, with the treatment distributed in a cross-over manner. 
Characteristics of the 
study treatments 
Carbonated 
1 serving = ingested dose 
Still 
1 serving 
Still 
Ingested  dose 
Energy (kcal) * < 10 < 10 < 12 
Green tea extract (mg) * 899 899 1364 
Total catechins (mg)* 230 230 349 
EGCG (mg) * 122 122 182 
Caffeine (mg) ** 106.5 66 100 
Calcium (mg) * 195 195 295 
Carbohydrate (mg) * 0 0 0 
Fat (mg) * 0 0 0 
CO2 (g) *** 6 0 0 
Serving size (mL) 355 330 500 
Table 1 Energy content and major ingredients in study treatments                     
Symbols: * According to recipe ; ** Measured by the Regional Laboratory of Nestlé ; *** Measured 
by Nestlé’s Product and Technology Center Marysville    
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4 Results 
 
Tables showing median, mean, standard deviation and range of the measurements are 
attached in Annex B.  
Graphics interpretation: Time 0 min: mean of the 15-min resting period; time 20-120: means 
over 10 min post-ingestion periods. Graphics (Fig. 6, 8, 9 and 11) represent median of the 
time intervals, averaged over all the subjects, during the pre- and post-ingestion periods. Fig. 
10 represents the caffeine concentration averaged over each subject at each saliva sampling. 
Fig. 7 represents the subtraction of the median of each post-ingestion time interval and the 
baseline, averaged over all the subjects, multiplied by the test duration. 
4.1 Physical characteristics of the subjects 
 
12 volunteers (5 men and 7 women) were enrolled and all completed the study with no 
major protocol violation. Therefore, all subjects were included into the intention-to-treat 
analysis set. 
Parameter Median Mean St. dev. Range 
Age (years) 35.0 37.2 8.3 24.0 – 50.0 
Weight (kg) 64.1 66.6 8.8 54.0 – 84.0 
Height (cm) 173.0 171.8 8.6 160.0 – 190.0 
Diastolic blood pressure (mmHg) 80 79 7.0 70 – 90 
Systolic blood pressure (mmHg) 120 120 7.1 110 – 130 
BMI (kg/m
2
) 22.2 22.5 1.7 20.2 – 25.3 
 
Table 3 Demographics and baseline characteristics of participants 
 
All volunteers drank the full treatment volume within 5 min, except one who left 39 mL of 
the still treatment. Compliance for abstinence from caffeine after the evening meal before 
V1 and V2 was confirmed by measurement of salivary caffeine immediately before products 
ingestion, which reached 4.8 µmol/L at maximum. This is below the threshold Astrup et al 
used in their study (5µmol/L) 8.  
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4.2 Primary Outcome: Energy Expenditure  
 
Figure 6 Energy expenditure over time, n = 12 
 
 
Figure 7 Change in energy expenditure, n = 12 
 
Between both treatments, no significant difference in change in energy expenditure was 
obtained (p = 0.850). This was reinforced by a supportive analysis (p = 0.908).  
Both treatments triggered an increase of 0.05 kcal/min from baseline (p = 0.038 for still and 
p = 0.020 for carbonated treatment), i.e. 6 kcal/120min. 
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4.3 Secondary Outcomes 
 
4.3.1 Substrate Oxidation 
 
All the observations on fat and carbohydrate oxidations were reinforced by measurement 
and statistical treatment of RQ and NPRQ (see in Annex B). 
Compared to the still treatment, the carbonated treatment induced significantly lower fat 
and higher carbohydrate oxidations (10.2 mg/min, p = 0.002, and 21.8 mg/min, p = 0.005, 
respectively). Carbonated treatment did not impact significantly substrate oxidation, 
compared to baseline (fat oxidation: p = 0.262, carbohydrate oxidation: p = 0.935). Still 
treatment significantly increased fat oxidation by 15.2 mg/min (p = 0.004), and decreased 
carbohydrate oxidation by 26.5 mg/min (p = 0.012), from baseline. 
 
 
Figure 8 Fat oxidation, n = 12 
 
 
Figure 9 Carbohydrate oxidation, n = 12 
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4.3.2 Caffeine Kinetics 
 
 
 
Figure 10 Salivary caffeine kinetics, n = 12 
 
 
Compared to the still treatment, the carbonated treatment induced higher caffeine 
concentration AUC and Cmax (increases by 10.1 µg.min/ml, p = 0.040 and 0.19 µg/ml, p = 
0.031, respectively). Tmax was not different between treatments (p = 0.693). 
 
4.3.3 Heart Rate  
 
Figure 11 Heart rate, n = 12 
 
 
Still and carbonated treatments induced a similar effect on heart rate (p = 0.130). 
Carbonated treatment showed a significant decrease of 3.67 bpm from baseline (p = 0.030), 
whereas no significant effect was observed for the still treatment (p = 0.958). 
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5 Discussion 
 
The present study was conducted to investigate the hypothesis that caffeine-induced 
increase in energy expenditure would be greater following ingestion of a carbonated 
beverage, compared to the same product in a still version. This hypothesis was based on the 
assumption that carbonation could increase caffeine absorption, and thus enhance the 
effects of this ingredient on metabolic rate.  
 
5.1 Caffeine Kinetics 
 
Comparing both products, results revealed significant increase in caffeine absorption (AUC, 
and Cmax enhanced) with the carbonated product. This is in line with our initial assumption, 
and supported by literature 54,22,28,43,65.  
Carbonation increased caffeine AUC by 10.1 µg.min/mL over 120 min. As caffeine is known 
to be completely absorbed in human13,19, the difference in AUC measured in this study does 
not reflect a difference in total quantity of absorbed caffeine. However, it may reflect a 
different pattern of absorption on a 120 minutes basis due to CO2 addition in the beverage.  
An increase in Cmax may attest of higher efficiency of caffeine to cross gastro-intestinal 
mucosa due to carbonation, as suggested by Eichman and Robinson28. 
Time to reach maximal concentration did not differ significantly between products (p = 
0.693). This is against the current available literature, where time to reach maximal 
concentration is reported to be shorter with carbonated compared to still treatment 
formulation. Indeed, with 18 volunteers, Di et al showed a decrease in Tmax with effervescent 
paracetamol compared to tablets (20.4 min compared to 38.4 min respectively)22. Moreover, 
Joshi et al observed that effervescent formulation of a novel coenzyme Q10 triggered faster 
Tmax than non-effervescent formulations (2.0 h and 3.7 h respectively)
40. Finally, Bonati et al  
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observed reduced Tmax after ingestion of 0.22 mg/kg of caffeine as soft-drink compared to 
sin-gas formulation 5.00 mg/kg as aqueous (38 min and 47 min respectively) 13.  
Looking deeper into Tmax distribution (see table 6B in Annex B and Fig. 12), discrepancies can 
be observed. Indeed, mean time to reach maximal concentration is much longer than its 
median. Out of 12 participants, 9 and 8 of them triggered a Tmax at T = 15 min in following 
ingestion of still and carbonated treatments, respectively, see Fig. 12.  However, the mean is 
2.5 min shorter with carbonated (25 min) than with still treatment (27.5 min). Although it is 
not significant, the trend of lower Tmax due to carbonation is observed here, as described in 
literature 13,22,40. It has to be mentioned that it is difficult to determine whether it reflects 
physiological values, or whether it was affected by the 15 min interval between each saliva 
sampling and the last measurement at 120 min with still study treatment, which would have 
impacted on the mean. Anyways, more accurate Tmax values would have been obtained if 
saliva sampling had been more frequent, leading to a normalization of Tmax distribution. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 Distribution of Tmax for both treatments, n = 12 
 
 
Salivary caffeine concentration has been shown to reflect plasma caffeine 
concentration6,33,52,72. Caffeine concentration can be monitored in saliva independently of 
the salivary pH or the flow33. The gold standard for this method is to rinse the mouth to 
remove the  caffeine that could remain and which would false real plasmatic concentration30.  
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In the present study, it was uneasy to have the subjects rinse their mouth after beverage 
ingestion, because the presence of the canopy over their head prevented them to spit. Since 
energy expenditure was the first outcome of this study, it was decided not to remove the 
canopy during the test, including during treatment ingestion, in order to avoid losing 
respiratory gas immediately after treatments ingestion. For this reason, treatments were 
ingested using a straw and intervals between saliva samplings were relatively long (15 min). 
As a consequence participants could not rinse their mouth following treatment ingestion. 
Therefore, caffeine kinetics may have been affected by non-physiological caffeine remaining 
in the saliva due to the drinking of the caffeinated test products, enhancing artificially AUC 
and Cmax. However, if this is the case, it is most likely that only the first saliva sampling would 
have been affected, since 100 mg caffeine was diluted in 355 mL or 500 mL. 
 The hypothesis of an artefact at the first measurement is reinforced by the fact that median 
Tmax are reached in 15 min with both treatments. Indeed, in the literature, caffeine Tmax is 
very widely distributed (from 15 to 120 min), but strong evidence is that time to reach 
maximal concentration is about 40 min 6,8,13,49,58. The fact that the still treatment presents a 
lower than expected Tmax indicates that the highest concentration present at the first post-
ingestion measurement is not due to carbonation, but more likely to residual caffeine in 
saliva, remaining from beverage ingestion.  
This artefact may have influenced the absolute values AUC, Cmax and Tmax, but not the 
differences between the two treatments for AUC and Cmax. Therefore, the observation that 
caffeine was better absorbed due to the presence of carbonation on a 120 min basis remains 
relevant. 
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5.2 Energy Expenditure  
 
5.2.1 Comparing Treatments 
 
The carbonation-induced increase in absorption of caffeine does not appear to have been 
sufficient to significantly affect energy expenditure in our study. This is against our initial 
hypothesis, which was that the change in energy expenditure between carbonated and still 
beverage versions would be different. Therefore, we could conclude that carbonation does 
not represent a solution to enhance the thermogenic functionality of caffeine. However this 
conclusion should be interpreted with caution, since the present study did not investigate 
the effect of pure caffeine into water but the effect of a mix of active ingredients. Moreover, 
the ingested volumes were not identical. As discuss below, these are factors that might have 
influenced our results.   
Increased Volume 
 
Study beverage is formulated to contain 100 mg caffeine. However, analysis of the caffeine 
content revealed that the batch of still treatment contained less caffeine (66 mg). As a 
consequence, the volume was adjusted so that both study beverages could contain 100 mg 
caffeine, which is a dose shown to affect the resting metabolic rate by 3-4 % over 2.5h 26. 
Therefore, 500 mL of the still beverage were necessary to insure this caffeine content, 
whereas 355 mL of the carbonated drink were sufficient to deliver 100 mg caffeine. 
Water Induced Thermogenesis 
 
Based on the results of Boschmann et al, it could be argued that the greater volume ingested 
with the still beverage lead to an increase in energy expenditure 15. In this study involving 14 
healthy subjects, drinking 500 mL of water led to an increase of energy expenditure of 30 %, 
60 min after beverage ingestion (p < 0.001). Despite the significant effect of water observed 
in this study, this article was challenged by a review17, which concluded, based on several 
other papers, that water did not enhance energy expenditure, by itself. Indeed, in a 
randomized crossover design where 8 human subjects ingested 7.5 mL/kg (about 518 mL) of  
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distilled water or 0.9 % saline solution, Brown et al, could not observe any effect on energy 
expenditure17. As this team does not support an effect of water volume per se on energy 
expenditure, the decision to match caffeine content rather than total volume ingested was 
taken in the present study.  
Temperature 
 
In the above described study, Boschmann et al suggested that energy expenditure was 
increased of 12 % only to fuel the warming of 500 mL water from 22° to 37°C 15. However, 
Brown et al reported an increase in EE of only 4.5 % due to ingestion of ~ 7.5 mL/kg distilled 
water at 3°C 17. Considering this number, ingestion of a still treatment volume surplus of 145 
mL at 3°C would lead to an increase of 1.3 % in EE, which could have been sufficient to hide 
an effect of carbonation on caffeine-induced effect on energy expenditure.  
Catechin Content 
 
Another aspect to consider is the fact that the increase of volume of the still treatment have 
led to an increase in GTE and its catechins, as well as calcium. The concentrations of these 
elements have not been measured, and it is therefore difficult to evaluate precisely their 
absolute quantity in 500 mL. According to recipe, the addition of 145 mL of still beverage 
increased absolute intake of catechin by 119 mg, bringing total ingested catechins amount 
to 349 mg in still compared to 230 mg in carbonated treatment. In the present study, the 
contribution of catechins cannot be distinguished from that of caffeine, due to the fact that 
no control was done with either caffeine or catechins alone. 
Dulloo et al found that daily ingestion of 375 mg catechins and 150 mg caffeine increased 
significantly 24h-EE by 2.8 % compared to 150 mg caffeine alone25. Such an effect of 
catechins on energy expenditure, beyond the effect of caffeine, has not been observed in 
several other studies 10,11,23,31,64,66. Indeed, Gregersen et al did not observe higher EE due to 
ingestion of caffeine (150 mg/d) and catechins (range from 493.8 to 684.0 mg/d) compared 
to same dose of caffeine alone. 
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Based on the above mentioned doses of catechins needed to significantly enhance EE it is 
likely that the increase in catechin content ingested with the extra volume of the still 
treatment (evaluated to 119 mg catechins) could not influence significantly EE. 
 
In summary, based on available literature, we can conclude that ingestion of the additional 
volume per se (145 ml) and of the additional quantity of catechins (119 mg), could not affect 
significantly energy expenditure. However, it is possible that the thermogenic cost of heating 
a surplus of beverage have influence the effect of the still treatment on energy expenditure. 
 
5.2.2 Treatment Effect                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  
This study could complement the research of Rudelle et al in investigating the effect of one 
single serving of beverage on energy expenditure. Indeed, these authors addressed the 
effect of three servings of a similar beverage (daily dose: 2100 mg GTE, 300 mg caffeine and 
633 mg calcium), and observed diurnal EE increased by 4.7 kcal/h compared to placebo (p = 
0.005) 63. This is comparable to the 6 kcal/h (compared to baseline) noticed in the present 
work which was achieved with a single beverage serving.  
Ingestion of either treatment in the present study showed an increase in EE of about 4.6 %. 
This is in the same range that the diurnal-EE observed in the study of Dulloo (increase of 
4.5 % due to ingestion of 150 mg caffeine and 375 mg catechins, compared to placebo) 25.  
The effect observed on 120-min EE is greater than what was reported by Dulloo and Rudelle 
during the diurnal phase of the tests. This may be attributable to the fact that we focus on a 
120 min effect –when the effect is suspected to be the highest–, whereas they measured EE 
for 24h and 23h, respectively. Indeed, caffeine maximal concentration in blood is reached in 
approximately 40 min 6,8,13,49, and that there is a correlation between plasma caffeine and 
thermogenic response 8. To cover the global effect of treatments on EE, it would have been  
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interesting to extend the measurement until energy expenditure return to baseline values. 
However, this would have probably required more than three hours, since neither Acheson 
et al, Astrup et al nor Dulloo et al could return to baseline after 3h measurements following 
administration of caffeine in a dose of 8 mg/kg body weight 3, or of 100 mg 8,26.  
 
Based on results from the present study and from the available literature, it seems 
reasonable to attest that carbonation by itself failed to enhanced caffeine and catechins-
induced increase in energy expenditure. It can also be concluded that one serving of 
beverage significantly increased 120 min-EE by 6 kcal. 
 
5.3 Substrate oxidation 
 
The still treatment induced significant changes from baseline, towards increase in fat and a 
decrease in carbohydrate (17.2 kcal and 13.3 kcal, respectively, over 120 min) oxidation, 
which is in line with literature 2,3. Indeed, Acheson et al reported an increase in change in fat 
oxidation following 8 mg/kg caffeine ingestion compared to placebo (fat oxidation was 
increased by 33 mg/min with caffeine, whereas it was only 16 mg/min with placebo, 
compared to respective baselines) 3. Moreover, in a study by Acheson et al, ingestion of 
caffeine (10 mg/kg) triggered higher lipid oxidation than baseline 2.  
 
If carbonation would enhance the effects of caffeine on substrate oxidation, an increase in 
fat and a decrease in carbohydrate oxidation would be expected with CO2 added recipe 
compared to sin-gas treatment, as described above 2,3,38. In contrast with the above 
mentioned studies, our results presented an inverse pattern. This indicates that either the 
higher volume of the still product has impacted substrate utilization, or that carbonation 
itself has an effect on substrate oxidation. 
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Increased content of active ingredients in still treatment may have triggered a higher impact 
on substrate oxidation. Catechins may trigger substrate oxidation towards fat rather than 
carbohydrate oxidation. Indeed, Dulloo et al reported lower RQ due to ingestion of 375 mg 
catechins and 150 mg caffeine, compared to same dose of caffeine alone 25. However, some 
studies also failed to demonstrate this effect of catechins on substrate oxidation 9-11,31,63,66. 
Indeed, Gregersen et al could observe no significant effect of GTE (150 mg caffeine and 
493.8 - 684.0 mg catechins) on RQ over 12.5h compared to placebo 31. Moreover, Thielecke 
et al did not observe a difference in fat oxidation between EGCG-caffeine mixtures (per day: 
caffeine fixed dose of 600 mg plus either 270, 600, 900 or 1200 mg EGCG) and 200 mg 
caffeine alone 66. Thus, the increase in catechin content in still compared to carbonated 
treatment could be an explanation of the inverted substrate oxidation pattern observed. 
However, this hypothesis is less plausible when one considers the small increase in catechins 
ingested and the conflicting literature.  
 
Another more plausible explanation in the context of this study is that drinking carbonated 
beverage may have lead to non-physiological CO2 appearance in exhaled gas, invalidating 
CO2 concentration measurements. Higher NPVCO2 leads to greater carbohydrate and lower 
fat calculated oxidations. Thus, the pattern observed following carbonated treatment 
ingestion could be explained by the treatment’s CO2 exhaled by the participants in the 
canopy, between two sips during treatment ingestion or afterwards due to gastric reflux. 
Similarly, this non-physiological CO2 may have also affected carbonated treatment’s-induced 
energy expenditure and also explain why compared to baseline, carbonated treatment failed 
to significantly affect substrate oxidation oxidations but showed a strong trend towards 
increased carbohydrate and lower fat oxidations compared to pre-ingestion values.  
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To evaluate the impact of the non-physiological presence of CO2, Fig. 13 and Fig. 14 show 
the evolutions of O2 consumption and CO2 production rates. Comparing these two figures, it 
appears that CO2 production at least during the first 40 min, reflects non-physiological values 
because this increase is not followed by O2 consumption.   
 
 
Although it could have been an interesting information, it was not possible to subtract 
beverage CO2 content to VCO2, due to the fact that it is not known how much CO2 was 
rejected during breathing, and how much stayed into the gastro-intestinal tract since gastric 
partial O2 and CO2 pressures were not monitored. 
 
Therefore, changes in substrate oxidation observed in this study could be influenced by the 
non-physiological CO2. Indeed, VCO2 is multiplied by a factor 1.106 in EE equation (Eq. 1), 
such that an increase in VCO2 would influence energy expenditure in a lower extend than 
NPVO2 which is has a factor of 1.69 for fat oxidation (Eq. 7) and 4.12 for carbohydrate 
oxidation (Eq. 8).  This could explain why carbohydrate oxidation is increased of 21.8 mg/min 
and fat oxidation decreased of 10.2 mg/min with still compared to carbonated treatment, 
whereas EE does not seem to be widely affected.   
 
Figure 13 Rate of CO2 production over time,  
for both treatments, n = 12 
Figure 14 Rate of O2 consumption over time, 
for both treatments, n = 12 
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The increased carbohydrate oxidation and decreased fat oxidation triggered by carbonated 
treatment compared to still (by 21.8 mg/min and 10.2 mg/min, respectively) correspond 
respectively to 10.93 kcal and 11.55 kcal over the 120 minutes of measurements, according 
to conversion factors of Livesey and Elia 46. The resulting difference of energy is then 0.62 
kcal, which is negligible on a 120 minutes test. Therefore, even if substrate oxidation was 
impacted differently by both beverages, this failed to differently influence energy 
expenditure. 
 
Regarding this artefact, carbonated treatment may not have triggered physiological 
substrate oxidation values and as a consequence, comparisons between beverages may not 
be accurate. However, ingestion of still treatment triggered real changes in substrate 
oxidation, which do reflect physiological variations, and indicate greater fat and lower 
carbohydrate oxidation. 
 
5.4 Heart Rate 
 
The non-significant effect of still treatment on heart rate compared to baseline, and the non-
significant differences comparing both products, were expected, based on the important 
doses of caffeine that need to be ingested to influence this parameter. Indeed, 400 mg of 
caffeine failed to increase significantly heart rate, from baseline in the study of Astrup et al 8. 
Moreover, 300 mg caffeine did not affect significantly heart rate, compared to placebo in 
the study of Rudelle et al 63. Acheson et al could not observe an effect of 10 mg/kg caffeine 
on heart rate, compared to baseline 2. It was therefore expected that a caffeine intake of 
100 mg would not modify heart rate significantly. 
Both products present the same non-significant trend towards an initial decrease of heart 
rate after test beverage ingestion, and a further regain. This pattern was already reported in  
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literature 8,61: Astrup et al noted that after 100, 200 or 400 mg caffeine intake, heart rate 
dropped by 3-4 bpm from 30 to 90 min post-ingestion, and raised afterwards (from 90 to 
180 min post-ingestion). Anticipation, which is known to increase importantly resting heart 
rate 50, could explain this pattern. Indeed, subjects may be anxious before and just after 
treatment ingestion, relaxed at mid-test, and willing the test to end towards the end of 
measurements.  
Carbonated treatment decreased significantly heart rate by 3.67 bpm, compared to baseline 
(p = 0.030). This is against the hypothesis that increased caffeine absorption increase heart 
rate. Thus, to the best of our knowledge, this result remains unexplained. 
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6 Conclusion 
 
 
The main goal of this study conducted as part of the Master thesis, was to assess the 
difference between the effects of two products, one carbonated and one still, containing 
similar amounts of caffeine and green tea catechins, on energy expenditure and substrate 
oxidation. 
 
The results of the present study suggest an increased caffeine absorption pattern over 2h 
due to CO2 addition in beverage formulation, which is in line with literature. Despite the 
increased caffeine absorption, energy expenditure was not increased by carbonation. This is 
probably mainly attributable to the fact that for a similar dose of caffeine, the small increase 
in caffeine absorption is not sufficient to enhance its effect on energy expenditure. Ingestion 
of one serving of either treatment leads to a 6 kcal increase in energy expenditure over 120 
min. Still treatment consumption shifted substrate oxidation towards fat burning and 
decreased the contribution of carbohydrate as a body fuel, as expected. Finally, ingestion of 
carbonated treatment decreased heart rate by 3.67 bpm.  
 
The results of this study will need to be reproduced to confirm our conclusions, since it was 
impossible to discard from the analysis the potential CO2 coming from the carbonated 
beverage, that may have interfered with gas exchange measurements during the ingestion 
of the carbonated treatment. It is also possible that absorption of the other active ingredient 
of the treatments (catechins and calcium) was affected by carbonation, or that their 
contents were increased together with the increase in still ingested volume.  
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A new design would be required to strengthen the present results. For instance, a 
carbonated water control could be added, to subtract the non-physiological CO2 from 
indirect calorimetry measurements. Another solution to solve the problem related to CO2 
measurement would be to test subjects with direct calorimetry. However, that would not 
allow insights on substrate oxidation and was not possible in the context of the present 
study since no time was available to identify an external lab where direct calorimetry 
measurements could have been preformed. Another improvement would be to measure 
caffeine concentration in plasma, rather than in saliva as it was done in the present study 
due to the absence of available nurse. This would avoid the artifact in salivary caffeine 
concentration coming from the impossibility to rinse the mouth during indirect calorimetry 
using a canopy. Finally, it is clear that the content of each active ingredient of next study’s 
treatments would be analyzed prior to the beginning of the study, to avoid any volume 
confounding factor. Although all the solutions listed above were explored and discussed 
during study planning, they could not be implemented due to limited resources and time for 
this project. 
 
A full understanding of the role of CO2 addition on substrate absorption would require to run 
cellular and tissular scale studies. Indeed, histology, pharmacology, gastroenterology and 
fluid dynamics could help develop a more holistic comprehension of CO2’s roles on different 
ingredients absorption. 
 
This study confirmed the effect of still beverage on energy expenditure and substrate 
oxidation, reinforcing its position as a thermogenic beverage. It confirmed that CO2 enhance 
the absorption of some ingredients, caffeine in the present context. But to draw firm 
conclusions on the other results, a new design would be required. 
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7 Annexes 
 
A: Subjects, Material and Methods 
B: Data and Results 
C: Dossier santé 
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Annex A: 
 
Subjects, Materials and Methods 
I. Protocole 
 
The protocol and informed consent were approved by an Independent Ethics Committee, the 
“Commission d’Ethique du Centre Hospitalier Universitaire Vaudois (CHUV)”. The trial was conducted 
according to the relevant legal and operational requirements (Good Clinical Practices, Standard 
Operating Procedures).  
 
1. Study design  
This study is a single center, randomized, single-blind, and controlled, cross-over clinical trial of two 
groups. It is aimed at testing the acute effect of carbonation into a caffeinated beverage on energy 
expenditure, substrate oxidation, caffeine absorption and heart rate. 
1.1 Inclusion and exclusion criteria 
 
The subjects had to comply with the following main inclusion criteria: age between 20 and 50 years 
old, healthy, men and women, BMI between 20 and 27 kg/m2. After having been informed of the 
study details, subjects had to be freely willing to participate to the study. 
The main exclusion criteria were smoking, history of diseases that could affect intestinal absorption 
or resting metabolic rate, intake of medication that could influence these parameters. Frequent 
practice of physical activity (> 300 min of moderate or intense exercise per week), pregnancy and 
intake of more than 5 cups of caffeine containing beverages per day were also judged as exclusion 
criteria. 
1.2 Study population 
 
Healthy Caucasian men and women matching inclusion criteria were recruited from April to May 
2010, at the Nestlé Research Center in Lausanne, Switzerland. Among 22 volunteers screened, 12 
were enrolled into the trial. 
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2. Product allocation 
Subjects were assigned to each of the 2 products randomly in a cross-over order and with sex as a 
stratification factor. 
 
2.1 Product description 
Test product 1 (Carbonated treatment): is a water based beverage containing natural citrus flavors, 
artificial sweeteners (aspartame, acesulfame K). One serving is 355 mL steel can. This serving 
contains the following active ingredients: 899 mg green tea extract (GTFT-X) of which 122 mg are 
epigallocatechin gallate, 195 mg of calcium, 100 mg caffeine (of which 35 mg is from the green tea 
extract and 65 mg from added caffeine) and 6g CO2. 
Test product 2 (Still treatment): is exactly the same recipe than product one, but it does not contain 
CO2, and it is served in a 330 PET bottle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1A Energy content and major ingredients in study treatments 
Symbols: * According to recipe ; ** Measured by Nestlé’s Regional Laboratory;  
*** Measured by Nestlé’s Product and Technology Center Marysville 
 
 
 
 
Characteristics of study 
treatments 
Carbonated 
1 serving = ingested dose 
Still 
1 serving 
Still 
Ingested  dose 
Energy (kcal) * < 10 < 10 < 12 
Green tea extract (mg) * 899 899 1364 
Total catechins (mg)* 230 230 349 
EGCG (mg) * 122 122 182 
Caffeine (mg) ** 106.5 66 100 
Calcium (mg) * 195 195 295 
Carbohydrate (mg) * 0 0 0 
Fat (mg) * 0 0 0 
CO2 (g) *** 6 0 0 
Serving size (mL) 355 330 500 
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2.2 Product distribution 
 
Products were stored at 4°C. Immediately before presenting them to the subjects, test beverages 
were poured into a glass. Test beverages were drunk in less than 5 min, with a straw put through the 
canopy.  
For quality reason, caffeine content of both beverages was assessed by the Regional Laboratory of 
Nestlé in Orbe. Unexpectedly, although the sparkling drink contained the indicated dose (100 mg), 
the still beverage contained only 66 mg. To correct this defect and insure a caffeine intake of 100 mg 
for each test beverages, a dose of 500 mL of still beverage was administered to the subjects, whereas 
the dose of carbonated drink remained 355mL. As shown in Table 1A, volunteers ingested the same 
dose of caffeine, even though the volumes were non identical. Catechin content of both products 
was not measured, and therefore the potential greater catechin intake due to volume addition is not 
known. 
 
3. Data collection, management and validation 
 
3.1 Data collection 
 
Participants were recruited internally, amongst NRC employees. The persons who responded to the 
recruitment add were first asked to fill-in the medical questionnaire. This was followed by a standard 
medical evaluation performed by the research Medical Doctor at NRC who ensured volunteer 
fulfilled the eligibility criteria. Decision to enroll or not subjects was taken afterwards. During their 
first visit, at V0, subjects received information on the study content and planning and were informed 
on the tests to be performed. They were shown the indirect calorimetry measurement setup, to 
allow them to familiarize with the canopy system. At the end of V0, they were given the informed 
consent with the instruction to return the form signed at the latest at V1 in order to be enrolled into 
the trial.  
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At the next visit, V1, the subjects were welcomed at the Metabolic Unit, asked to fulfill the 
compliance questionnaire, weighted by medical staff. Subjects were then comfortably installed in 
semi-recumbent position in a reclining bed, wearing a ~ 15L Plexiglas canopy. After a stabilization 
period of ~ 5 min, resting metabolic rate was measured for 15 minutes, as shown in table 2A. 
Volunteers were then asked to ingest the randomly assigned treatment beverage contained in a glass 
within 5 min with a straw put through the ventilated canopy.  During beverage ingestion, energy 
expenditure measurements were stopped. The energy expenditure measurement (postprandial 
phase) continued for another 120 min as shown in table 2A.  
Heart rate was recorded by using a portable device on the chest of the participants during all the 
energy expenditure measurements (pre- and post-prandial phases), see table 2A. 
Immediately before drinking the test product, and at time 15, 30, 45, 60, and 120 minutes after 
ingestion of the test beverages, volunteers were asked to chew cottons wool swabs for the 
harvesting of saliva. This is, schematized in table 2A. 
After 120 minutes post-ingestion, measurement were terminated, canopy removed from over 
participants head, and participants were invited to go to the adjacent dining room where they were 
offered a breakfast. 
Parameter  Stabilisation Pre-ingestion Ingestion Post-ingestion 
Time (min)                        -20                            -5                           0          15         30         60         90       //      120  
Salivette                                                         S0                                      S1         S2        S3         S4               S5  
EE  
Sub. Ox. 
Heart rate  
No 
measurement 
15 min 
measurement 
No 
measurement 
120 min measurement 
 
Table 2A Phases of measurement, timing and saliva sampling 
V2 was identical to V1, but the test product was given in a crossover manner. 
Over all, the clinical testing lasted 6 weeks. 
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3.2 Procedures: 
 
In order to eliminate as many confounding factors as possible, the subjects were tested after a 10-h 
over-night fast. They were asked not to consume food (except water) after 22h00 on the evening 
before V1 and V2. Moreover, consumption of caffeine was not permitted after the evening meal 
before V1 and V2, to allow for clearance of caffeine which has a half-life reported to last from 4.9 ± 
1.8 58 to 10 hours 55,61,62, depending on gender and use of oral contraceptives. 
On the test days, volunteers were requested to use their car or public transportation to come to NRC 
in order to keep morning physical activity level as low as possible. 
During the tests, participants were asked not to fall asleep, to move and speak as less as possible, but 
they could watch television. 
Between the visits, they were asked to continue on their usual diet and physical activities. 
As menstrual stage has been shown to influence energy expenditure 20, women were tested only in 
the follicular phase of their cycle. 
 
3.3 Sample size: 
 
 
Since the literature on the influence of carbonation on the effects of caffeine is very limited, 
it was not possible, to do any power calculation to evaluate the number of subjects to enroll 
into the trial. Since this study was considered a pilot trial it was arbitrarily decided to test 15 
participants, with an estimated dropout rate of 20 %. That is 12 participants needed to 
complete the study. 
Participants recruited at the Nestlé Research Center are known to be relatively compliant. 
Moreover, the trial did not have many constraints, which could be challenging for study 
participants and increase risk of drop outs. Therefore, it was chosen to do the analyses as  
 
 Annex A                                                                                                                                                                VI 
 
 
per-protocol but not as intention-to-treat. It was planned that subjects withdrawing from 
the study would not be treated as per protocol.  
 
3.4 Data management and quality aspects 
 
 
All the data captured by the investigator were directly recorded on the paper case report forms. Data 
entry was done at NRC into the Clintrial® database with double entry.  
Height and weight measurements, as well as saliva sampling were assessed by health professionals, 
following the appropriate SOPs. A control of eventual caffeine ingestion before the tests was done by 
measuring the caffeine concentration in saliva prior to beverage ingestion. Research assistants were 
present during the entity of indirect calorimetry tests, as recommended in the relevant SOP.  
Energy expenditure results were provided electronically (Excel files) to data manager after a manual 
selection of interesting variables. More precisely, minutes of test beverages ingestion and saliva 
sampling were not considered in the statistical analysis. 
 
The caffeine content of the test beverages was analyzed by the Regional Laboratory, with a certified 
method.  
Caffeine concentration in saliva was dosed in duplicates, under supervision of a metabonomics 
expert, using a new UPLC-ESI-MS/MS method. 
All data were processed by the data management group, and the statistics were performed by a 
qualified statistician. 
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II. Techniques and measurements 
 
 
1. Energy expenditure measurements 
 
The measurements were performed with the MAX-II device provided by AEI technologies, Naperville, 
IL, USA. The sampling rate of the MAX-II machine is 2 averaged samples per minute. EE 
measurements were obtained directly from the MAX-II device, which uses the equations of Weir 67, 
see Eq. 1.  
Resting: At the beginning of the measurements, values are unstable due to stabilization of gas 
concentrations in the mixing chamber and subject habituation to the conditions of the environment. 
These values were not taken into consideration and the recording of data begun after this 5-10 min 
stabilization period (see table. 2A), when the RQ and the fraction of expired CO2 (FeCO2) became 
stable. 
A recording of resting energy expenditure of 15 min was then performed.  
After this base line measurement, volunteers were given the test product. The measures during 
ingestion were discarded. 
Postprandial: Post-ingestion energy expenditure of the volunteers was monitored for 120 min. 
 
2. Substrate oxidation:  
 
Carbohydrates and fat utilization as well as RQ and NPRQ were calculated using the VO2 and VCO2 
values obtained from the MAX-II device during the same timeline than energy expenditure.  
As protein oxidation represents a minimal part of whole oxidation in a normal situation (no 
prolonged starvation, no diabetes, no acidosis) 46, protein oxidation was not measured in the present 
study, but it was estimated from the weight of the subjects, see Eq.3. 
Equations used by statisticians to derive substrate oxidation and respiratory quotients were the 
equations mentioned in introduction 46 (Eq. 8, Eq. 7, Eq. 2 and Eq.6). 
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3. Biological samples: 
 
Sample collection: 
Saliva samples were collected with Sarstedt Salivette tissues without citric acid provided by 
SARSTEDT AG & Co, Nümbrecht, Germany. 
The sampling was done by passing the Starstedt Salivette to the mouth of the participant with a 
forceps into a hole in the canopy, let the subject turn it into his mouth for 2 minutes, and collect the 
cotton wool swab via the same hole in the canopy. 
As soon as they were collected, the Starstedt Salivette cottons were centrifuged at 3500 rpm during 
10 minutes. The collected saliva (around 1mL) was then separated into two ependorf tubes, and 
frozen at (-80°C).  
Analysis of the caffeine content of the saliva samples: 
A technique using UPLC-ESI-MS/MS was developed in the scope of this study to analyze salivary 
caffeine content. It was an improvement in the field, because this technique allowed an analysis of 
caffeine content in saliva without any pre-treatment of the samples within 10 min. Further 
information about this method is available in Annex Aa. 
Caffeine was quantified by ultra pressure liquid chromatography coupled to  electrospray 
ionization tandem mass spectrometry (UPLC- ESI-MS/MS) on a turbulent flow chromatography 
system (TLX1 from ThermoFisher) coupled to a 3200 Q TRAP mass spectrometer (AB  Sciex). 
Chromatography separation was realized on a BEH C18 reverse phase column (2.1 x 100 mm, 1.7 µm, 
Waters Corp.). 
MS/MS parameters were optimized to monitor two main caffeine and 3C13-labelled caffeine 
transitions reactions. They are, for caffeine:  m/z 195→138 (collision energy: 25 eV) and m/z 
195→110 (collision energy: 30 eV); and for 3C13-labelled caffeine (internal standard) 
transitions:  m/z 198→140 (collision energy: 25 eV) and m/z 198→112 (collision energy 30 eV). 
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Parameter [unit] Value 
Source  temperature [°C] 400 
Entrance potential [V] 10 
Cell exit potential [V] 10 
Pressure of the collision gas (nitrogen) [Torr] 5 x 10-3 
Curtain gas (nitrogen) [arbitrary unit] 20 
Ion spray voltage [V] 3000 
Nebuliser gas (nitrogen), Ion source gas 1 [V] 30 
Nebuliser gas (nitrogen) ,  Ion source gas 2 [V] 20 
Declustering potential [V] 51 
 
Table 3A: Optimization of  the ESI-MS/MS parameters for quantification of salivary caffeine content 
 
Linearity of calibration through a calibration panel ranging from 0 to 75 µg/mL caffeine was 
demonstrated. Calibration stability over time was challenged with the same calibrant solutions 10 
days apart. The stability over time was necessary to address, because the same calibrant solutions 
were used on the 3 days of the tests. 
During the testing, a calibration curve was derived every 20 test samples to ensure the quality of 
the data. These calibrations are superimposed to show their reproducibility.  The calibration curve 
was linear over the saliva caffeine concentrations measured (below 2  µg/mL) and calibrations were 
stable in this range. 
Once the method was fully functional, all the samples were defrosted (10h at 5°C). For every sample, 
300 µL of saliva was added to 10 µL of 13C3-caffeine (100 µg/mL solubilised in water) in a vial. The 288 
resulting saliva samples were then injected into the LC-MS instrument, and the whole analysis was 
realized within 3 days. 
 
4. Heart rate:  
 
Heart rate was measured by using a polar heart rate transmitter (FS1 Polar Electro Europe BV). This 
device is made of a chest-belt recording heart rate, which emits to an antenna connected to a 
computer. Heart rate was recorded simultaneously to energy expenditure. 
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III. Statistical treatment 
 
To test the difference of effects on energy expenditure (kcal/min), substrate oxidation (mg/min and 
no unit) and heart rate (bpm) between the two products, a mixed effects model was used. The model 
accounted for product (Carbonated or still treatment) and baseline (REE, resting fat and 
carbohydrate oxidation (mg/min), pre-ingestion RQ and NPRQ (no unit), and resting heart rate 
respectively) as fixed effects and subject ID as a random effect.  
To reinforce the result for the primary outcome, a supportive analysis was performed on energy 
expenditure: the median of measurements over 5 periods of 24 minutes was calculated and a 
repeated measures analysis was applied on this data. 
In order to asses if there is a beverage effect (change score of energy expenditure, substrate 
oxidation, RQ, NPRQ and heart rate) post-ingestion compared to resting values were analyzed by a 
one sample t-test. Statistics were performed by subtracting pre-ingestion median to post-ingestion 
median for each subject. These differences were then averaged over all the subjects. Therefore, the 
graphics display means (all the subjects), but both means and medians are shown in the tables. 
Finally, the effect of both products on Cmax (µg/mL) and AUC (µg.min/mL) of caffeine concentration in 
saliva were compared by a paired t-test. The difference in time to reach maximal concentration (min) 
was addressed by applying a log-rank test. 
The data were not cleaned prior to statistical treatment, but the periods in which the participant 
drank the treatment, chew the salivettes, spoke or went to the toilets were discarded and not taken 
into account in the statistics. 
The beverage codes were broken after the protocol and intention-to-treat data sets had been 
defined and the primary outcome had been analyzed. The codes were: A, Still treatment; and B, 
Carbonated study treatment.  
For the statistical analysis, software R version 9.2.9 (Lucent Technologies) was used. 
P value < 0.05 is considered to be significant. 
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1. Energy expenditure  
 
The primary outcome is the change, between treatments, in the median of post-ingestion energy 
expenditure PIEE (kcal/min) to resting energy expenditure REE (kcal/min), averaged on all subjects.  
A secondary outcome is the treatment effect, compared to baseline: PIEE-REE for each product 
(kcal/min).  
 
2. Substrate oxidation  
 
A secondary outcome is the change, between treatments, in the median of post-ingestion 
carbohydrate oxidation (mg/min) to pre-ingestion carbohydrate oxidation (mg/min), averaged on all 
subjects. 
Another secondary outcome is the treatment effect, compared to baseline: the median of post-
ingestion carbohydrate oxidation (mg/min) - pre-ingestion carbohydrate oxidation (mg/min) for each 
treatment, averaged on all subjects. 
Fat oxidation was analyzed as for carbohydrate utilization. 
Change in RQ (post-ingestion RQ (no unit) - pre-ingestion RQ (no unit)) was also analyzed for each 
treatment, as an additional insight in substrate oxidation. The treatment effect itself was also 
triggered, compared to baseline. 
NPRQ was addressed identically as RQ. 
 
3. Caffeine absorption  
 
A secondary outcome is the difference, between treatments, in maximum concentration (Cmax 
(µg/mL)) and time to reach this concentration (Tmax (min)) as well as AUC (min.µg/mL) of caffeine 
concentration in saliva in post-ingestion period compared to resting period. 
 
4. Heart rate  
 
Another secondary outcome is the change, between treatments, in heart rate (bpm) in post-
ingestion period compared to resting period. 
Additional secondary outcome is the treatment effect, compared to baseline: the median of post-
ingestion heart rate (bpm) - pre-ingestion heart rate (bpm) for each product, averaged on all subjects. 
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Annex Aa:  
 
UPLC method to assess salivary caffeine concentration  
 
Quantitative analysis of caffeine content from saliva samples: 
Caffeine was quantified by ultra pressure liquid chromatography coupled to tandem mass 
spectrometry (UPLC-MS/MS) on a turbulent flow chromatography system (TLX1 from ThermoFisher) 
coupled to a 3200 Q TRAP mass spectrometer (ABSciex). Each saliva sample was analyzed in 
duplicates. Chromatography separation was realized on a BEH C18 reverse phase column (2.1 x 100 
mm, 1.7 µm. Waters Corp.). LC solvents used were: A) water containing 0.05% acetic acid and B) 
acetonitrile containing 0.05% acetic acid. A linear gradient was used as the following: 0 min ( 
 A 5 µL injection was achieved from the saliva samples. MS source parameters were optimized as the 
following: spray voltage: 3000 V, source temperature: 400°C, nebuliser gases (nitrogen): GS1: 30 and 
GS2: 20, curtain gas (nitrogen): 20, declustering potential: 51 V, collision gas (nitrogen) 5 mTorr, 
entrance and collision cell exit potentials: EP: 10 and CXP: 10 V. Data acquisition was realized in 
positive electrospray ionization mode using selected reaction monitoring (SRM) by following the 
transition reactions of m/z 195138 and 195110 (respective collision energies of 25 and 30 eV) 
for caffeine and m/z 198140 and 198112 (respective collision energies of 25 and 30 eV). The 
dwell time was fixed at 20 msec for each transition with an inter-scan delay of 5 msec. 
Quantification of caffeine was obtained by plotting the area ratio of the highest SRM signal of 
caffeine versus 13C3-caffeine against concentration (m/z 195110 / 198112). A 5-data point was 
used to build the calibration curve, ranging from 0-75 µg/mL of caffeine (100 µg/mL of 13C3-caffeine). 
Standard solutions, solubilised in water, were injected every day to ensure the consistency of the 
results over time (days). Quantification was realized using Analyst software (version 1.5, AB Sciex). 
 
Another SRM transition was used as qualifier to ensure the integrity of peak integration for both 
caffeine and its isotopically labelled internal standard. As example, the area ratio of caffeine (m/z 
195140 / 195110) and 13C3-caffeine (m/z 198140 / 198112) have to be constant 
independently of the analyte concentration.  
 
Batch sequence: 
Typically, calibrant samples were injected at the beginning and end of each batch, followed by a 
blank sample. After 20 saliva samples, 2 calibrant standards were injected as quality control samples 
to check the absence of analytical drift. 
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Results & Discussion 
 
Optimisation of UPLC-MS/MS conditions 
Caffeine and 13C3-caffeine standard solutions were infused into the MS and source parameters were 
optimised to provide the best signal response in positive ionization full scan mode. Once these 
parameters were set, collision induced dissociation experiments were realized by selecting the 
protonated species under various collision energies. Figure 1Aa depicts the typical CID mass spectra 
obtained for caffeine and 13C3-caffeine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15Aa: Collision induced dissociation of caffeine (a & b) and 13C3-caffeine (c & d). a and c were 
acquired at a collision energy of 25 eV, whereas b & d at 35 eV. 
 
 
Analysis of saliva samples 
In order to provide a high throughput of analysis, saliva sample submitted to a centrifugation step 
was spiked with the isotopically internal standard in an LC vial and directly analyzed by UPLC-MS/MS. 
These preliminary experiment trials were done to assess if removing the clean-up step before 
analysis was possible or not. The various SRM traces did not revealed co-eluting peaks (Figure 2Ab).  
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Moreover, the peaks of caffeine were strong enough and did not reveal any major ion suppression 
issues, which are sometimes encountered using LC-MS/MS. Therefore, all the saliva samples were 
processed under similar conditions. 
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Figure 16Ab: SRM transitions observed for calibrant (a-c) and saliva sample (b & d). a & b depict 
the caffeine traces whereas c & d its corresponding internal standard. 
 
 
Quantification of caffeine 
As initial trial, a broad range of caffeine concentration was used to build the calibration curve 
(ranging from 0-75 µg/mL). A good linearity was obtained from 0-25 µg/mL, which was ideal for the 
caffeine present in the saliva samples. 
Once the method was fully functional, all the samples were defrosted (10h at 5°C). For every sample, 
300 µL of saliva was added to 10 µL of 13C3-caffeine (100 µg/mL solubilised in water) in a vial. The 288 
resulting saliva samples were then injected into the LC-MS instrument, and the whole analysis was 
realized within 3 days.  
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Annex B: 
 
Data and Results 
 
 
The characteristics of energy expenditure, substrate oxidation, caffeine concentration and 
heart rate measurements during pre- and post-ingestion periods for both treatments are 
presented in the following tables. 
 
 
 
1. Energy expenditure  
Energy expenditure (kcal/min) 
Product Period Median Mean St. dev. Range 
Still treatment 
Pre 1.03 1.07 0.16 0.83 – 1.52 
Post 1.08 1.12 0.17 0.73 – 2.05 
Carbonated treatment 
Pre 1.02 1.06 0.16 0.72 – 1.71 
Post 1.06 1.11 0.20 0.80 – 2.65 
 
Table 1B: Energy expenditure, n = 12 
 
 
 
 
 
 
 
2. Substrate oxidation (fat and carbohydrate oxidations, RQ and NPRQ)  
Fat oxidation (mg/min) 
Product Period Median Mean St. dev. Range 
Still treatment 
Pre 56.6 52.9 19.7 -4.6 – 93.9 
Post 66.4 68.5 19.8 -1.2 – 198.6 
Carbonated treatment 
Pre 57.8 54.4 19.4 10.3 – 109.1 
Post 56.7 58.6 25.4 -14.6 – 244.7 
 
Table 2B: Fat oxidation, n = 12  
 
Carbohydrate oxidation (mg/min) 
Product Period Median Mean St. dev. Range 
Still treatment 
Pre 88.3 92.2 46.4 17.4 – 241.4 
Post 64.8 67.7 33.8 -55.3 – 269.0 
Carbonated treatment 
Pre 84.1 84.9 37.5 12.6 – 215.7 
Post 82.5 88.4 45.9 -136.1 – 354.3 
 
Table 3B: Carbohydrate oxidation, n = 12  
 
On top of these measurements presented in the thesis, we have measured respiratory 
quotient and non-protein respiratory quotient. 
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Respiratory quotient (no unit) 
Product Period Median Mean St. dev. Range 
Still treatment 
Pre 0.83 0.83 0.05 0.75 – 0.98 
Post 0.80 0.80 0.03 0.68 – 0.97 
Carbonated treatment 
Pre 0.82 0.83 0.04 0.75 – 0.93 
Post 0.82 0.82 0.05 0.64 – 1.01 
 
Table 4B: Respiratory quotient, n = 12 
 
Non-protein respiratory quotient (no unit) 
Product Period Median Mean St. dev. Range 
Still treatment 
Pre 0.83 0.83 0.06 0.73 – 1.02 
Post 0.79 0.79 0.04 0.67 – 1.01 
Carbonated treatment 
Pre 0.82 0.82 0.05 0.73 – 0.95 
Post 0.82 0.82 0.06 0.62 – 1.05 
 
Table 5B: Non-protein respiratory quotient, n = 12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1B: Respiratory quotient,   n = 12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2B: Non-protein respiratory quotient, n = 12 
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Consistent with their effects on substrate oxidation, the treatments affected RQ and NPRQ 
differently. Indeed, compared to baseline, still treatment significantly decrease RQ and 
NPRQ (by 0.03, p = 0.006 and 0.04, p = 0.007, respectively). Compared to baseline, 
carbonated treatment did not significantly affect RQ and NPRQ (p = 0.576 and p = 0.611, 
respectively). Comparing both products, carbonated treatment significantly increased RQ 
(0.02, p = 0.003) and NPRQ (0.03, p = 0.003). 
 
 
3. Salivary caffeine kinetics  
Caffeine concentration: AUC (min.ug/ml), Cmax(ug/ml), Tmax(min) 
Product Measure Median Mean St. Dev. Range 
Still treatment 
AUC 135.1 137.8 14.5 116.2 – 160.1 
Cmax 1.38 1.45 0.30 1.09 – 2.10 
Tmax 15.0 27.5 30.6 15.0 – 120.0 
Carbonated treatment 
AUC 144.9 147.9 17.1 129.5 – 185.2 
Cmax 1.57 1.65 0.33 1.18 – 2.23 
Tmax 15.0 25.0 16.1 15.0 – 60.0 
 
 
Table 6B: Caffeine concentration in saliva, n = 12 
 
 
 
4. Heart rate  
Heart rate (bpm) 
Product Period Median Mean St. dev. Range 
Still treatment 
Pre 64.0 66.2 13.6 49.0 – 153.0 
Post 63.0 66.9 18.0 42.0 – 175.0 
Carbonated treatment 
Pre 64.0 64.7 8.5 46.0 – 92.0 
Post 61.0 61.7 9.2 41.0 – 114.0 
 
Table 7B: Heart rate, n = 12 
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Annex C : 
 
Dossier Santé 
 
 
 
Tout d’abord, je tenais à vous remercier chaleureusement pour votre participation au projet. 
Le but du présent dossier est de vous communiquer les résultats des examens que vous avez 
effectués dans le cadre de cette étude: dépense énergétique et fréquence cardiaque. Vous 
serez invité au group meeting de « Energy and Metabolic Health » où je présenterai les 
résultats de l’étude, et pourrez avoir accès au R&D report dans Documentum. 
 
Dépense énergétique de repos: 
 
La mesure de la dépense énergétique au repos permet d’évaluer la quantité de calories 
brulées lorsque vous êtes dans une situation minimale d’activité. Cela correspond à la 
quantité de calories utilisés par votre corps lorsque vous êtes couché et immobile. Dans ces 
conditions, la valeur obtenue représente la quantité de calories utilisées par vos organes et 
vos muscles. Lorsqu’elle est  extrapolée sur 24h, cette valeur représente vos besoins 
caloriques quotidiens minimaux, auxquels s’ajoute la quantité de calories utilisées par votre 
corps pour réaliser toutes les autres activités de votre vie quotidienne. La dépense 
énergétique de repos peut  ensuite être multipliée par un facteur d’activité (voir tableau 
« niveaux d’activité physique » ci-dessous), représentatif de votre niveau d’activité 
(sportives et non-sportives) pratiquées au quotidien. La valeur ainsi obtenue est une 
estimation de votre dépense énergétique totale qui correspond à la quantité de calories qui, 
lorsque consommées, devraient vous permettre de garder un poids constant. Cette valeur 
vous est donnée à titre indicatif et est sujette au changement, selon votre niveau d’activité 
qui peut varier au quotidien.  
 
Dans le cadre de cette étude, la dépense énergétique de repos à été mesurée à l’aide de la 
calorimétrie indirecte. Cette technique évalue la concentration d’O2 et de CO2 présents dans 
les gaz expiratoires à jeun et au repos strict. 
 
Votre dépense énergétique de repos, moyennée entre les deux visites, a été évaluée à 
1715.5 kcal/jour.   
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En vous référant au tableau ci-dessous, vous pouvez multiplier cette valeur par le facteur 
d’activité correspondant à votre situation. La valeur obtenue est une indication de vos 
besoins énergétiques caloriques quotidiens.   
Par exemple, si votre dépense énergétique de repos a été mesurée à 1500 kcal par jour, et 
que vous êtes très sédentaire (valeur du niveau d’activité physique : 1.4), vous aurez une 
dépense énergétique réelle de : 1500 x 1.4 = 2100 kcal par jour. 
 
Niveaux d’activité physique :   
Catégorie du style de vie Valeur du niveau d’activité (sans unités) 
Sédentaire ou faible activité 1.40-1.69 
Modérément actif ou actif 1.70-1.99 
Très actif 2.00-2.40 
Source : Food and Agriculture Organization of the United Nations 
http://www.fao.org/docrep/007/y5686e/y5686e07.htm 
 
 
En général, chez l’homme adulte qui pratique un niveau d’activité physique faible, la 
dépense énergétique totale (dépense énergétique de repos + dépense énergétique des 
activités)  se situe autours de 2500 kcal/jour.  
 
Voici les valeurs de référence pour des hommes adultes : 
Calories nécessaires (kcal) Activité physique 
Age (années) Faible Moyenne Forte 
19-30 2500 2700 3000 
31-50 2350 2600 2900 
Source : santé canada : http://www.hc-sc.gc.ca/fn-an/food-guide-aliment 
 
Voici les valeurs de référence pour des femmes adultes : 
 
Calories nécessaires (kcal) Activité physique 
Age (années) Faible Moyenne Forte 
19-30 1900 2100 2350 
31-50 1800 2000 2250 
Source : santé canada : http://www.hc-sc.gc.ca/fn-an/food-guide-aliment 
 
 
 
 
Fréquence cardiaque : 
 
Lors de cette étude, seules la fréquence cardiaque de repos, et celle induite par la boisson 
ont été évaluées. La fréquence  cardiaque à l’effort n’a pas été mesurée, bien que ce soit elle 
qui donne une réelle idée de la santé cardiaque. En effet, la fréquence de repos n’atteste pas 
de la santé du cœur ; elle est plutôt indicative du degré d’activité physique quotidien et du 
niveau de stress. 
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Votre fréquence cardiaque au repos, moyennée entre les deux visites est de : 55.6 
battements par minute. 
 
En général, la fréquence cardiaque au repos est située entre 58 et 74 battements par minute. 
N Repos Anticipation 
Entrainé Non entrainé Entrainé Non entrainé Entrainé Non entrainé 
5 4 67 69 148 124 
5 4 67 67 130 115 
4 4 63 68 129 118 
4 4 62 70 122 129 
4 4 58 64 118 128 
4 4 59 74 108 109 
 
Source : McArdle W.D. et al. “Telemetered cardiac response to selected running events”, J. Appl. 
Physiol, 23:566, 1967 
 
Voici quelques éléments d’interprétation de votre fréquence cardiaque de repos : 
Une personne sportive a une fréquence cardiaque de repos plus faible qu’une personne 
sédentaire.  
Par ailleurs, dans la présente étude, les volontaires étaient allongés, ce qui peut entrainer 
une diminution de la fréquence cardiaque. 
Une haute fréquence cardiaque de repos peut être expliquée par l’anticipation d’une 
situation inconnue, … 
 
 
 
J’espère que ce dossier vous aura permis de mieux appréhender vos besoin caloriques 
journaliers et donné une idée de votre fréquence cardiaque de repos.  
Merci encore sincèrement d’avoir pris part à cette étude clinique! 
 
 
 
 
 
